StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/309% below fair value
$0.83−0.02 (-2.80%)

Close on Nov 18, 2026Market cap $36.76MP/E –Yield –

Elutia net income

Net income is the profit left for shareholders after every expense, interest and tax.

Elutia's net income for the twelve months ending Jun 30, 2026 was $51.81M. For fiscal 2025 it was $53.38M. The highest annual figure on record is $53.38M in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$53.38M–
FY2024Dec 31, 2024-$53.95M–
FY2023Dec 31, 2023-$37.66M–
FY2022Dec 31, 2022-$32.90M–
FY2021Dec 31, 2021-$24.83M–
FY2020Dec 31, 2020-$21.83M–
FY2019Dec 31, 2019-$11.94M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.65M–
Q1 FY2026Mar 31, 2026-$7.47M–
Q4 FY2025Dec 31, 2025$70.79M–
Q3 FY2025Sep 30, 2025-$3.87M-400.8%
Q2 FY2025Jun 30, 2025-$9.61M–
Q1 FY2025Mar 31, 2025-$3.93M–
Q4 FY2024Dec 31, 2024-$9.06M–
Q3 FY2024Sep 30, 2024$1.29M–
Q2 FY2024Jun 30, 2024-$28.18M–
Q1 FY2024Mar 31, 2024-$17.99M–
Q4 FY2023Dec 31, 2023-$9.31M–
Q3 FY2023Sep 30, 2023-$9.75M–
Q2 FY2023Jun 30, 2023-$10.62M–
Q1 FY2023Mar 31, 2023-$7.97M–
Q2 FY2022Jun 30, 2022-$9.40M–
Q1 FY2022Mar 31, 2022-$8.15M–
Q4 FY2021Dec 31, 2021-$9.06M–
Q3 FY2021Sep 30, 2021-$8.32M–
Q2 FY2021Jun 30, 2021-$2.39M–
Q1 FY2021Mar 31, 2021-$5.07M–
Q4 FY2020Dec 31, 2020-$5.36M–
Q3 FY2020Sep 30, 2020-$6.73M–
Q2 FY2020Jun 30, 2020-$5.18M–
Q1 FY2020Mar 31, 2020-$4.56M–
Q4 FY2019Dec 31, 2019-$2.78M–
Q3 FY2019Sep 30, 2019-$3.10M–

More Elutia figures

See a number that looks wrong?